Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer (Q44530805)

From Wikidata
Jump to navigation Jump to search
scientific article published in August 2003
edit
Language Label Description Also known as
English
Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer
scientific article published in August 2003

    Statements

    Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer (English)
    M Kaufmann
    I Fogelman
    J C de Haes
    M Schumacher
    W Sauerbrei
    Zoladex Early Breast Cancer Research Association (ZEBRA) Trialists' Group
    1 August 2003
    1711-1717

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit